 |
인쇄하기
취소
|
Green Cross obtains exclusive distribution rights for somatostatin injection
Green Cross Corporation said on July 24 it has signed an agreement with he Korean subsidiary of Merck KGaA Germany for the exclusive distribution rights in Korea for Stilamin injection (somatostatin acetate).
Somatostain injection was developed by Merck KGaA for the treatment of acute variceal bleeding.
“With this agreement, GCC not only helps improve patients’ quality of life, but also e...
Somatostain injection was developed by Merck KGaA for the treatment of acute variceal bleeding.
“With this agreement, GCC not only helps improve patients’ quality of life, but also e...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.